Source: Annual Congress 2006 - COPD and systemic inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. M. Möller, M. A. Spruit, H. J. Pennings, J. D. Does, P. P. Janssen, E. F. M. Wouters (Maastricht, Horn, Netherlands). Self-reported comorbidity and C-reactive protein in patients with COPD. Eur Respir J 2006; 28: Suppl. 50, 755

Member's Comments

No comment yet.

Related content which might interest you: Relationships between C-reactive protein and disability in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005 Proteomic analysis of plasma from COPD patients and smoking control subjects Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007 Clinical value of C-reactive protein in severe acute exacerbations of COPD Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 Ubiquitin expression is up-regulated in peripheral muscle in elderly patients with COPD Source: Annual Congress 2006 - COPD comorbidity Year: 2006 Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Expression profiling of Th17 associated molecules in bronchoalveolar cells from patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011 Baseline self-reported comorbidity in COPD patients referred for pulmonary rehabilitation (PR) Source: Annual Congress 2006 - COPD comorbidity Year: 2006 Prognostic value of C-reactive protein in patients with severe to very severe chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006 Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 Active smoking negatively affects recovery of patients hospitalized due to acute exacerbation of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Smoking rate: smoking cessation interventions Year: 2011 Subpopulation structure of lymphocytes in patients with chronic obstructive pulmonary disease (COPD) during exacerbation and after treatment Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Effects of an acute exacerbation requiring hospitalisation (AE) on lung function, muscle force and serum IGF-I levels in male patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 564s Year: 2002 Phenotypic markers of asthma and COPD at the tissue level Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Quantitative CT characterisation of stable COPD patients relates to COPD severity and exacerbation frequency Source: Annual Congress 2006 - COPD: imaging and computer applications Year: 2006 The relationship between depression, medication and stage of the disease in patients with COPD Source: Annual Congress 2006 - COPD comorbidity Year: 2006 Reduced myofibrillar protein breakdown in stable patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 459s Year: 2004 Usefulness of admission red cell distribution Width as a predictor of early mortality in patients with severe exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 High-sensitivity cardiac troponin T is associated with increased mortality in patients with stable chronic obstructive pulmonary disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Validation of two physical activity questionnaires in a population of patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 632s Year: 2004